ClinVar Miner

Submissions for variant NM_001009944.3(PKD1):c.6994_7000dup (p.Val2334fs)

dbSNP: rs1555453872
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000501173 SCV000592797 pathogenic Autosomal recessive polycystic kidney disease criteria provided, single submitter clinical testing
Cavalleri Lab, Royal College of Surgeons in Ireland RCV001095637 SCV001251278 pathogenic Polycystic kidney disease, adult type 2020-02-05 criteria provided, single submitter research PVS1, PM2, PP4
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV001095637 SCV001368016 pathogenic Polycystic kidney disease, adult type 2016-01-01 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic.
Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research RCV001249167 SCV001422372 pathogenic not provided 2019-01-01 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV001095637 SCV002802647 pathogenic Polycystic kidney disease, adult type 2021-07-17 criteria provided, single submitter clinical testing
Eurofins-Biomnis RCV001095637 SCV003935046 pathogenic Polycystic kidney disease, adult type 2022-10-24 criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV001095637 SCV004100656 pathogenic Polycystic kidney disease, adult type criteria provided, single submitter clinical testing The frameshift duplication p.V2334Gfs*88 in PKD1 (NM_001009944.3) has been reported to ClinVar as Pathogenic by multiple laboratories.The p.V2334Gfs*88 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation. For these reasons, this variant has been classified as Pathogenic.
Juno Genomics, Hangzhou Juno Genomics, Inc RCV001095637 SCV005184190 pathogenic Polycystic kidney disease, adult type 2024-07-19 criteria provided, single submitter clinical testing PM2_Supporting+PVS1+PS4_Moderate+PP4
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV001095637 SCV005374427 pathogenic Polycystic kidney disease, adult type 2024-09-22 criteria provided, single submitter clinical testing
Genomics England Pilot Project, Genomics England RCV001095637 SCV001760369 pathogenic Polycystic kidney disease, adult type no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.